12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers
- Vivos Therapeutics (NASDAQ:VVOS) shares moved upwards by 105.4% to $0.38 during Wednesday's regular session. The current volume of 201.6 million shares is 13196.4% of Vivos Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $11.3 million.
- Nuvalent (NASDAQ:NUVL) shares moved upwards by 31.37% to $55.73. Trading volume for this security as of 13:30 EST is 3.9 million, which is 1095.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $3.1 billion.
- Histogen (NASDAQ:HSTO) stock moved upwards by 27.11% to $0.65. Histogen's stock is trading at a volume of 2.3 million shares as of 13:30 EST. This is 1121.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $2.7 million.
- MiNK Therapeutics (NASDAQ:INKT) stock increased by 24.57% to $1.09. Trading volume for MiNK Therapeutics's stock is 83.9K as of 13:30 EST. This is 126.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $37.6 million.
- Brainstorm Cell (NASDAQ:BCLI) shares rose 18.94% to $0.2. As of 13:30 EST, this security is trading at a volume of 37.9 million shares, making up 6171.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $9.1 million.
- Gritstone Bio (NASDAQ:GRTS) shares increased by 18.18% to $2.4. As of 13:30 EST, this security is trading at a volume of 9.6 million shares, making up 838.8% of its average full-day volume over the last 100 days. The company's market cap stands at $223.3 million.
Losers
- Inhibikase Therapeutics (NASDAQ:IKT) shares fell 33.2% to $0.93 during Wednesday's regular session. The current volume of 9.1 million shares is 18995.5% of Inhibikase Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $5.0 million.
- Protagenic Therapeutics (NASDAQ:PTIX) shares declined by 32.56% to $1.16. The current volume of 152.2K shares is 3202.4% of Protagenic Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $5.0 million.
- Standard BioTools (NASDAQ:LAB) stock decreased by 24.06% to $2.05. As of 13:30 EST, Standard BioTools's stock is trading at a volume of 3.0 million, which is 1205.8% of its average full-day volume over the last 100 days. The company's market cap stands at $161.9 million.
- Nuwellis (NASDAQ:NUWE) stock declined by 19.69% to $1.02. Trading volume for Nuwellis's stock is 160.8K as of 13:30 EST. This is 169.3% of its average full-day volume over the last 100 days. The company's market cap stands at $1.9 million.
- Lipella Pharmaceuticals (NASDAQ:LIPO) shares fell 19.49% to $1.24. The market value of their outstanding shares is at $7.1 million.
- MSP Recovery (NASDAQ:LIFW) stock decreased by 18.84% to $0.2. Trading volume for MSP Recovery's stock is 13.8 million as of 13:30 EST. This is 37.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $67.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.